Skip to main content

Mektovi Prices, Coupons, Copay Cards & Patient Assistance

Mektovi (binimetinib) is a member of the multikinase inhibitors drug class and is commonly used for Melanoma - Metastatic, and Non Small Cell Lung Cancer.

The cost for Mektovi 15 mg oral tablet is around $17,171 for a supply of 180 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Mektovi is available as a brand name drug only, a generic version is not yet available. View generic Mektovi availability for more details.

Mektovi prices

Oral Tablet

15 mg

Mektovi oral tablet

 from $17,171.42

for 180 tablets
Quantity Per unit Price
180 $95.40 $17,171.42

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Mektovi Coupons, Copay Cards and Rebates

Mektovi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Mektovi Pfizer Oncology Together Co-Pay Savings Program

Eligible commercially insured patients may pay as little as $0 per treatment with savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.

Applies to:
Mektovi
Number of uses:
12 times within calendar year
Expires
December 31, 2026

Form more information phone: 877-744-5675 or Visit website

Mektovi Pfizer Oncology Together Mail-In Rebate

If a pharmacy does not accept the Savings Card the patient may submit a request for a rebate in connection with the offer; for additional information contact the program at 877-744-5675.

Applies to:
Mektovi
Number of uses:
One rebate per prescription fill
Expires
December 31, 2026

Form more information phone: 877-744-5675 or Visit website

Patient Assistance & Copay Programs for Mektovi

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Mektovi (binimetnib) Tablet

More information please phone: 866-316-7263 Visit Website

Provider: Pfizer Patient Assistance Program

Eligibility requirements:
  1. Uninsured or Underinsured
  2. Varies
  3. Not specified
  4. Must be residing in the US or US territory
  5. Pfizer also has programs that provide eligible patients with insurance, support assistance, and medicines at a savings. Contact Pfizer RxPathways for details (844-989-7284).
Applicable drugs:
  • Mektovi (binimetnib) Tablet

More information please phone: 866-706-2400 Visit Website

Provider: Pfizer Oncology Together

Eligibility requirements:
  1. Contact program for details.
  2. At or below 300% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be under treatment from a US doctor.
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Mektovi (binimetnib) Tablet

More information please phone: 877-744-5675 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.